Cardiac genetics offers a compelling test case for digitally enabled precision medicine—where the convergence of genomics and continuous data has the potential to fundamentally reshape how risk is understood, monitored, and managed. This session will explore these themes as well as the potential for interventional therapies that can fundamentally change outcomes.
Can Gene Therapy Deliver the Promise of Personalized EP Therapy?
September 18, 2026 | 04:45 PM (EDT) - 05:30 PM (EDT)